New Research Shows Significant Benefits for COPD Patients in the Home Using Fisher & Paykel Healthcare’s myAirvo
- Friday, April 20, 2018, 1:45
- Business
- Add a comment
AUCKLAND, New Zealand, April 20, 2018 /PRNewswire/ — Fisher & Paykel Healthcare Corporation Limited announced today that new research has been published in the International Journal of COPD which demonstrates significant benefits of nasal high flow therapy for COPD* patients using…
Source: https://www.prnewswire.com/news-releases/new-research-shows-significant-benefits-for-copd-patients-in-the-home-using-fisher–paykel-healthcares-myairvo-300633563.html
About the Author
adminasapcorp has written 39590 stories on this site.